Literature DB >> 35906460

Laparoscopic segment 4b+5 liver resection for stage T3 gallbladder cancer.

Long Huang1,2, Chenjun Zhang1,2, Yifeng Tian1,2, Chengyu Liao1,2, Maolin Yan1,2, Funan Qiu1,2, Songqiang Zhou1,2, Zhide Lai1,2, Yaodong Wang1,2, Ye Lin3, Shi Chen4,5.   

Abstract

BACKGROUND: There is still controversy over whether to perform laparoscopic surgery for T3 stage gallbladder cancer. In addition, the necessity of segment 4b+5 liver resection for stage T3 gallbladder has not been reported. This article aims to explore the safety, effectiveness, and short-term prognosis of laparoscopic segment 4b+5 liver resection for T3 stage gallbladder cancer.
METHODS: This is a retrospective multicenter propensity score-matched study. Disease-free survival, perioperative complications, and intraoperative safety were analyzed to evaluate safety and effectiveness.
RESULTS: There was no significant difference in the incidence of intraoperative bleeding, number of lymph nodes obtained, postoperative complications, or disease-free survival (DFS) between the open group (OG) and laparoscopic group (LG) (P > 0.05). The DFS time of the S4b+5 resection group (S4b5) was longer than that of the wedge group (P = 0.016). Cox regression showed that positive margins (HR, 5.32; 95% CI 1.03-27.63; P = 0.047), lymph node metastasis (HR, 2.70; 95% CI 1.31-5.53; P = 0.007), and liver S4b+5 resection (HR, 0.30; 95% CI 0.14-0.66; P = 0.003) were independent risk factors for DFS. The operative time of indocyanine green (ICG) fluorescence-guided liver S4b5 segment resection was shorter than that of traditional laparoscopic S4b+5 resection guided by hepatic veins (P ≤ 0.001).
CONCLUSION: Laparoscopic liver S4b+5 resection for T3 stage gallbladder cancer is safe and feasible and can prolong DFS. ICG fluorescence-guided negative staining may reduce the difficulty of the operation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Gallbladder cancer; Laparoscopy; Segment IVb; T3 stage; V resection

Year:  2022        PMID: 35906460     DOI: 10.1007/s00464-022-09325-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  5 in total

1.  Visualization of routes of lymphatic drainage of the gallbladder with a carbon particle suspension.

Authors:  K Uesaka; K Yasui; T Morimoto; A Torii; Y Yamamura; Y Kodera; T Hirai; T Kato; T Kito
Journal:  J Am Coll Surg       Date:  1996-10       Impact factor: 6.113

2.  [Analysis of the relationship between the number of lymph nodes examined and prognosis for curatively resected gallbladder carcinoma: a multi-institutional study].

Authors:  R Zhang; Y H Wu; D Zhang; Y J Zhang; Y H Qiu; N Yang; T Q Song; J Y Lou; J T Li; X H Mao; S P Li; S B Si; Z Q Cai; C Chen; Z M Geng; Z H Tang
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2020-04-01

3.  Lymph node evaluation in gallbladder cancer: which role in the prognostic and therapeutic aspects. Update of the literature.

Authors:  G Piccolo; M Di Vita; A Cavallaro; R Fisichella; A Zanghì; D Spartà; F Cardì; A Cappellani
Journal:  Eur Rev Med Pharmacol Sci       Date:  2014-12       Impact factor: 3.507

4.  [Analysis for the short-term efficacy and long-term prognosis of laparoscopic and laparotomy radical resection for gallbladder cancer].

Authors:  C W Dou; C X Zhang; J Liu; J Cheng; L M Jin; J W Liu; C W Zhang
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2022-02-01

Review 5.  Gallbladder cancer: epidemiology and outcome.

Authors:  Rajveer Hundal; Eldon A Shaffer
Journal:  Clin Epidemiol       Date:  2014-03-07       Impact factor: 4.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.